Benzinga - Gainers
- SeqLL Inc. (NASDAQ: SQL) shares rose 125% to $1.89 in pre-market trading after dropping around 39% on Thursday. SeqLL recently announced the establishment of a two-year Cooperative Research and Development Agreement with the U.S. Department of Justice's Federal Bureau of Investigation.
- Expion360 Inc. (NASDAQ: XPON) rose 51.4% to $3.00 in pre-market trading after the company was selected by Cube Series as exclusive supplier of lithium-ion batteries for ultralightweight foldable camper.
- HEXO Corp. (NASDAQ: HEXO) shares rose 30.7% to $1.83 in pre-market trading after dropping over 10% on Thursday. HEXO recently increased production of its straight edge pre-rolls and launched enhanced inhalation technology.
- Ecoark Holdings, Inc. (NASDAQ: ZEST) rose 26.7% to $0.3802 in pre-market trading. Ault Alliance and Ecoark Holdings, on Thursday, signed a share exchange agreement.
- enCore Energy Corp. (NYSE: EU) shares rose 13.1% to $2.67 in pre-market trading. enCore Energy recently closed C$34.5 million public offering.
- Alteryx, Inc. (NYSE: AYX) rose 10.7% to $66.52 in pre-market trading after the company reported better-than-expected fourth-quarter financial results.
- Hillstream BioPharma, Inc. (NASDAQ: HILS) rose 10.1% to $1.30 in pre-market trading after dropping around 14% on Thursday. Hillstream BioPharma recently announced acceptance of abstract at AACR 2023 Annual Meeting highlighting HSB-510 as novel bi-functional inhibitor for solid tumors & leukemias.
- Edible Garden AG Incorporated (NASDAQ: EDBL) rose 9.9% to $4.65 in pre-market trading. Edible Garden, on Thursday, announced research partnership with the New Jersey Institute of Technology, the USDA, and the Environmental Protection Agency to study nanobubble technology.
- VistaGen Therapeutics, Inc. (NASDAQ: VTGN) rose 9.4% to $0.1551 in pre-market trading after dropping around 24% on Thursday. VistaGen Therapeutics recently reported a Q3 FY23 net loss of $(9.8) million or $(0.05) per share.
- Aeva Technologies, Inc. (NYSE: AEVA) rose 8.7% to $1.88 in pre-market trading after dropping over 9% on Thursday.
- Hempacco Co., Inc. (NASDAQ: HPCO) fell 46.1% to $2.37 in pre-market trading after jumping more than 482% on Thursday.
- Lyft, Inc. (NASDAQ: LYFT) shares fell 33% to $10.87 in pre-market trading after the company issued Q1 revenue guidance below analyst estimates. Several analysts, including, Keybanc, Truist Securities and DA Davidson downgraded the stock following earnings.
- AppHarvest, Inc. (NASDAQ: APPH) shares dropped 18.2% to $1.08 in pre-market trading after the company announced pricing of $40 million underwritten public offering of 40 million shares of common stock at a price of $1 per share.
- PainReform Ltd. (NASDAQ: PRFX) fell 17.8% to $0.62 in pre-market trading. PainReform recently announced the receipt of an extension to meet the Nasdaq's minimum bid price requirement.
- Surrozen, Inc. (NASDAQ: SRZN) fell 14.1% to $0.9715 in pre-market trading after climbing 45% on Thursday.
- Wearable Devices Ltd. (NASDAQ: WLDS) shares fell 13.6% to $0.7850 in pre-market trading. Wearable Devices shares jumped over 45% on Thursday after the company received approval from the Israel Innovation Authority for a $900,000 grant.
- Blue Star Foods Corp. (NASDAQ: BSFC) fell 13.2% to $0.3190 in pre-market. Blue Star Foods recently engaged ShareIntel to combat alleged illegal short selling.
- Altisource Portfolio Solutions S.A. (NASDAQ: ASPS) fell 13.2% to $5.48 in pre-market trading after the company reported an underwritten public offering of shares of common stock.
- SelectQuote, Inc. (NYSE: SLQT) fell 12.2% to $1.80 in pre-market trading after climbing over 35% on Thursday. SelectQuote recently reported better-than-expected Q2 results and raised the lower end of its FY23 sales guidance above estimates.
- Bright Green Corporation (NASDAQ: BGXX) fell 8.1% to $0.82 in pre-market trading after dropping over 13% on Thursday. The company appointed Seamus McAuley, Chief Operating Officer of Bright Green, as Chief Executive Officer.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.